Exosomal miRNAs as biomarkers for diagnostic and prognosticin lung cancer

被引:59
|
作者
Wu, Jing [1 ]
Shen, Zuojun [1 ,2 ]
机构
[1] Anhui Med Univ, Anhui Prov Hosp, Dept Clin Lab, 17 Lu Jiang Rd, Hefei 230001, Anhui, Peoples R China
[2] Univ Sci & Technol China, Affliated Hosp 1, Div Life Sci & Med, Dept Clin Lab, Hefei, Anhui, Peoples R China
来源
CANCER MEDICINE | 2020年 / 9卷 / 19期
关键词
biomarker; diagnostic; exosomal miRNA; lung cancer; non-coding RNA; prognostic; EXTRACELLULAR VESICLES; POTENTIAL BIOMARKER; PLASMA; MARKERS; ADENOCARCINOMA; EXPRESSION; ANGIOGENESIS; METASTASIS; MICRORNAS; LAVAGE;
D O I
10.1002/cam4.3379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More and more studies report that exosomes released by various cells can serve as a medium for information exchange between different cells. Through a deep understanding of the physical and chemical properties of exosomes, the researchers revealed a more precise molecular mechanism of its participation in the process of intercellular communication. In particular, microRNA (miRNA) is found inside exosomes, as well as long noncoding RNA (lncRNA). Extensive evidence indicates that exosomal miRNAs participates in the occurrence and development of lung cancer and plays a variety of roles. Therefore, the release of RNA-containing exosomes in many different kinds of body fluids has caused widespread interest among researchers. In this review, we report evidence from human studies involving miRNAs and other ncRNAs in exosomes associated with lung cancer as diagnostic and prognostic markers. Currently, there is a small amount of evidence that exosomal miRNAs can be used as early diagnosis and prognostic markers for lung cancer, and their exact role in lung cancer patients still needs further study.
引用
收藏
页码:6909 / 6922
页数:14
相关论文
共 50 条
  • [1] Exosomal miRNAs as biomarkers of recurrent lung cancer
    Munagala, Radha
    Aqil, Farrukh
    Gupta, Ramesh C.
    TUMOR BIOLOGY, 2016, 37 (08) : 10703 - 10714
  • [2] Exosomal miRNAs in peripheral blood as novel diagnostic biomarkers of radioresistant lung adenocarcinoma
    Zhu, C.
    Wang, L.
    Zhang, Q.
    Xu, H.
    Tong, J.
    Wan, Y.
    Zheng, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S62 - S63
  • [3] Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
    Zhang, Zhijun
    Tang, Youyong
    Song, Xingguo
    Xie, Li
    Zhao, Shuping
    Song, Xianrang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [4] Exosomal miRNAs as cancer biomarkers and therapeutic targets
    Thind, Arron
    Wilson, Clive
    JOURNAL OF EXTRACELLULAR VESICLES, 2016, 5
  • [5] Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma
    Xin-ying Xue
    Yu-xia Liu
    Chen Wang
    Xin-jin Gu
    Zhi-qiang Xue
    Xue-lei Zang
    Xi-dong Ma
    Hui Deng
    Rong Liu
    Lei Pan
    San-hong Liu
    Signal Transduction and Targeted Therapy, 5
  • [6] Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease
    Manna, Ida
    De Benedittis, Selene
    Quattrone, Andrea
    Maisano, Domenico
    Iaccino, Enrico
    Quattrone, Aldo
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 16
  • [7] Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma
    Xue, Xin-ying
    Liu, Yu-xia
    Wang, Chen
    Gu, Xin-jin
    Xue, Zhi-qiang
    Zang, Xue-lei
    Ma, Xi-dong
    Deng, Hui
    Liu, Rong
    Pan, Lei
    Liu, San-hong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [8] Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease
    Yao, Y-F
    Qu, M-W
    Li, G-C
    Zhang, F-B
    Rui, H-C
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (16) : 5278 - 5283
  • [9] The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer
    Schwarzenbach, Heidi
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (09) : 1159 - 1169
  • [10] Exosomal miRNAs as Biomarkers of Cancer: a Meta-Analysis
    Yang, Bo
    Xiong, Wan-Yuan
    Hou, Huai-Ding
    Xu, Qian
    Cai, Xiao-Ling
    Zeng, Tong-Xu
    Ha, Xiao-Qin
    CLINICAL LABORATORY, 2019, 65 (05) : 789 - 799